Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (81-90 of 217) with videos related to

Pageof 22
Sort By:
Cancer Research and Treatment|July 8, 2016
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal CancerKyu-Pyo Kim, Jeong-Eun Kim, Yong Sang Hong, et al.
Clinical Therapeutics|November 20, 2009
Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteersTae-Eun Kim, Bo-Hyung Kim, JaeWoo Kim, et al.
Pancreas|January 6, 2005
Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitisMoon Hee Song, Myung-Hwan Kim, Sung Koo Lee, et al.
Cancers|April 30, 2021
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary ReviewChanghoon Yoo, Sang Hyun Shin, Joon-Oh Park, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Process Innovation Improves Trial Operation EfficiencyYun Jung Choi, Kyu-Pyo Kim, Sumi Park, et al.
Oncology Letters|September 25, 2020
Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence?Hyungwoo Cho, Jeong Eun Kim, Sun Young Kim, et al.
Cancer Immunology Research|April 9, 2020
CD226<sup>hi</sup>CD8<sup>+</sup> T Cells Are a Prerequisite for Anti-TIGIT ImmunotherapyHyung-Seung Jin, Minkyung Ko, Da-Som Choi, et al.
In Vivo (Athens, Greece)|March 1, 2020
Rivaroxaban <i>Versus</i> Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary CancerJwa Hoon Kim, Seyoung Seo, Kyu-Pyo Kim, et al.
Human Pathology|September 25, 2014
Survival effect of tumor size and extrapancreatic extension in surgically resected pancreatic cancer: proposal for improved T classificationHosub Park, Soyeon An, Soo-Heang Eo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2014
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patientsJeong Eun Kim, Yong Sang Hong, Jae-Lyun Lee, et al.
Pageof 22

Showing results (81-90 of 217) with videos related to

Sort By:
Pageof 22
Cancer Research and Treatment|July 8, 2016
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal CancerKyu-Pyo Kim, Jeong-Eun Kim, Yong Sang Hong, et al.
Clinical Therapeutics|November 20, 2009
Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteersTae-Eun Kim, Bo-Hyung Kim, JaeWoo Kim, et al.
Pancreas|January 6, 2005
Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitisMoon Hee Song, Myung-Hwan Kim, Sung Koo Lee, et al.
Cancers|April 30, 2021
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary ReviewChanghoon Yoo, Sang Hyun Shin, Joon-Oh Park, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Process Innovation Improves Trial Operation EfficiencyYun Jung Choi, Kyu-Pyo Kim, Sumi Park, et al.
Oncology Letters|September 25, 2020
Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence?Hyungwoo Cho, Jeong Eun Kim, Sun Young Kim, et al.
Cancer Immunology Research|April 9, 2020
CD226<sup>hi</sup>CD8<sup>+</sup> T Cells Are a Prerequisite for Anti-TIGIT ImmunotherapyHyung-Seung Jin, Minkyung Ko, Da-Som Choi, et al.
In Vivo (Athens, Greece)|March 1, 2020
Rivaroxaban <i>Versus</i> Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary CancerJwa Hoon Kim, Seyoung Seo, Kyu-Pyo Kim, et al.
Human Pathology|September 25, 2014
Survival effect of tumor size and extrapancreatic extension in surgically resected pancreatic cancer: proposal for improved T classificationHosub Park, Soyeon An, Soo-Heang Eo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2014
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patientsJeong Eun Kim, Yong Sang Hong, Jae-Lyun Lee, et al.
Pageof 22